Yoshida, Tamami http://orcid.org/0000-0002-4571-1362
Hashimoto, Motomu http://orcid.org/0000-0002-9241-060X
Kawahara, Rie http://orcid.org/0000-0003-3503-7375
Yamamoto, Hiroko http://orcid.org/0000-0001-9241-3870
Tanaka, Masao http://orcid.org/0000-0002-8942-2933
Ito, Hiromu http://orcid.org/0000-0002-1827-382X
Masuda, Izuru http://orcid.org/0000-0002-5665-9782
Hosoda, Kiminori http://orcid.org/0000-0002-4574-5239
Yamamoto, Wataru http://orcid.org/0000-0002-0810-4221
Uozumi, Ryuji http://orcid.org/0000-0002-9546-9869
Morita, Satoshi
Fujii, Yasutomo http://orcid.org/0000-0002-2821-6079
Mimori, Tsuneyo http://orcid.org/0000-0003-0016-2053
Nin, Kazuko
Article History
Received: 27 April 2018
Accepted: 25 June 2018
First Online: 4 July 2018
Compliance with ethical standards
:
: Masao Tanaka and Motomu Hashimoto are affiliated with the department that is financially supported by four pharmaceutical companies (Mitsubishi-Tanabe, Chugai, Ayumi, and UCB Japan) and a city government (Nagahama city). Masao Tanaka has received research grants from Astellas, Abbvie, Pfizer, and Taishotoyama. Motomu Hashimoto has received a research grant from Astellas. Hiromu Ito has received a research grant and/or speaker fee from Bristol-Myers, Astellas, Asahi-Kasei, and Eli Lily. Tsuneyo Mimori has received research grants from Acterion, Astellas, Asahi-Kasei Pharma, Ayumi, Chugai, Daiichi Sankyo, Eisai, JB, Mitsubishi-Tanabe, MSD, Nippon Shinyaku, Pfizer, Sanofi, and Takeda, and has participated in speakers’ bureaus for Astellas, Bristol-Myers Squibb, Chugai, and Mitsubishi-Tanabe. Kiminori Hosoda has received research Grants from Omron Health Care Co., Ltd.